Meridian Venture Partners II GP, L.P. - Mar 11, 2025 SCHEDULE 13D/A Report for ANI Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ANIP)

Filing Manager: Meridian Venture Partners II GP, L.P.
Reporting Manager: Robert E. Brown, Jr.
Security: ANI Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol: ANIP
Shares outstanding: 21.9M shares
Disclosed Ownership: 1.18M shares
Ownership: 5.4%
Form type: SCHEDULE 13D/A
Date filed: 3/13/2025, 08:50 PM
Date of event: Mar 11, 2025
Next filing: Aug 22, 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Meridian Venture Partners II GP, L.P. ("GP")	5.4%	1.16M	0	1.16M	/s/ Robert E. Brown, Jr.	Robert E. Brown, Jr.	0001580170
Meridian Venture Partners II, L.P.	5.4%	1.16M	0	1.16M	/s/ Robert E. Brown, Jr.	Robert E. Brown, Jr.	0001109507
Meridian Venture Partners II, Co.	5.4%	1.16M	0	1.16M	/s/ Robert E. Brown, Jr.	Robert E. Brown, Jr.	0001580169
Robert E. Brown, Jr.	5.4%	1.18M	20.2K	1.16M	/s/ Robert E. Brown, Jr.	Robert E. Brown, Jr.	0001579672